This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Weiterführende Literatur
Baessler A, Fischer M, Schunkert H (2003) Die chronische Herzinsuffizienz — ein oft vermeidbares Schicksal. Dtsch Med Wochenschr 128:1489–1493
Cleland IG; Swedberg K, Poole-Wilson PA (1998) Successes and failures of current treatment of heart failure. Lancet 352(Suppl):SI19–28
Cowie MR, Wood DA, Coats AJS, Thompson SG, Poole-Wilson PA, Suresh V, Sutton GC (1999) Incidence and prevalence of heart failure; a population-based study. Eur Heart J 20: 421–428
Dahlof B, Lindholm LH, Hansson L, Schersten B, Ekbom T, Wester PO (1991) Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet 338:1281–1285
Fischer M, Baessler A, Holmer SR et al. (2003) Epidemiologie der linksventrikulären systolischen Dysfunktion in der Allgemeinbevölkerung Deutschlands: Ergebnisse echokardiografischer Untersuchungen einer großen Bevölkerungsstichprobe. Z Kardiol 92:294–302
Fischer M, Baessler A, Hense HW et al. (2003) Prevalence of left ventricular diastolic dysfunction in the community. Results from a Doppler echocardiographic-based survey of a population sample. Eur Heart J 24:320–328
Ghali JK, Kadakia S, Cooper R, Ferlinz J (1988) Precipitating factors leading to decompensation of heart failure. Arch Intern Med 148:2013–2016
Kalantar-Zadeh K, Block G, Horwich T, Fonarow GC (2004) Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol 43:1439–1444
Kannel WB, Dannenberg AL, Levy D (1987) Population implications of electrocardiographic left ventricular hypertrophy. Framingham Heart Study. Am J Cardiol 60:851–931
McDonagh TA, Woodward M, Morrison CE (1997) Helicobacter pylori infection and coronary heart disease in the North Glasgow MONICA population. Eur Heart J 18:1257–1260
Michalsen A, Konig G, Thimme W (1998) Preventable causative factors leading to hospital admission with decompensated heart failure. Heart 80:437–441
Mosterd A, Hoes AW, deBruyne MC, Deckers JW, Linker DT, Hofman A, Grobbee DE (1999) Prevalence of heart failure and left ventricular dysfunction in the general population. Eur Heart J 20:447–455
Pitt B, Zannad F, Remme WJ et al. (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. RALES Investigators. N Engl J Med 341:709–717
Schunkert H, Broeckel U, Hense HW, Keil U, Riegger GA (1998) Left-ventricular dysfunction. Lancet 351:372
Teerlink JR, Goldhaber SZ, Pfeffer MA (1991) An overview of contemporary etiologies of congestive heart failure. Am Heart J 121:1852–1853
Wang TJ, Evans JC, Benjamin EJ, Levy D, LeRoy EC, Vasan RS (2003) Natural history of asymptomatic left ventricular systolic dysfunction in the community. Circulation 108:977–982
Wirth A, Sharma A, Schunkert H (2000) Kardiomyopathie bei Adipositas — eine Krankheitsentität. Dtsch Med Wochenschr 125:944–949
Rights and permissions
Copyright information
© 2005 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
(2005). Definition und Epidemiologie. In: Rationelle Diagnostik und Therapie bei Herzinsuffizienz. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-27906-7_1
Download citation
DOI: https://doi.org/10.1007/3-540-27906-7_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-23762-4
Online ISBN: 978-3-540-27906-8
eBook Packages: Medicine (German Language)